Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC)

NCT03972189 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

ROS1-positive Non-Small Cell Lung Cancer (NSCLC)

Interventions

DRUG: TQ-B3101

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.